EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Ion Channels for Cancer Therapy: From Pathophysiological Mechanisms to Clinical Translation

Sha Zhou, Xiong Song, Weian Zeng, Dongtai Chen iD

Pharmaceuticals · 10.10.2025 · 18 (10) · 1521

DOI: 10.3390/ph18101521 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.10.2025. Verfasst von Sha Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provinc…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a major global health burden, representing one of the leading causes of mortality among noncommunicable diseases worldwide. Although conventional treatment modalities, including surgical resection, chemotherapy, radiotherapy, targeted therapy, and immunotherapeutic interventions, have demonstrated clinical benefits, their therapeutic efficacy is often constrained by inherent limitations such as low specificity, systemic toxicity, or tumor heterogeneity. These challenges underscore the imperative for developing innovative treatment strategies. Emerging evidence has implicated ion channels as critical players in oncogenesis and cancer progression. These proteins modulate diverse oncogenic phenotypes, including uncontrolled proliferation, metastatic dissemination, and apoptotic resistance. Their frequent dysregulation in malignancies correlates with disease aggressiveness and clinical outcomes, positioning them as promising targets for precision oncology. Notably, pharmacological modulation of ion channels exerts multifaceted antitumor effects, with several channel-targeting agents advancing through clinical trials. This review explores recent advances in ion channel-targeted therapies, emphasizing their mechanisms, clinical applications, and challenges. Furthermore, we examine the pathophysiological contributions of ion channels to tumor biology and evaluate their emerging utility as predictive biomarkers, providing perspectives on addressing critical gaps in current oncologic management.

Schlagwörter

Stichwörter der Autor:innen

cancerion channelstherapeutic targettumor biology

Autor:innen und Institutionen

  • Department of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer…

ORCID-Profile: Dongtai Chen

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhou, S., Song, X., Zeng, W., & Chen, D. (2025). Targeting Ion Channels for Cancer Therapy: From Pathophysiological Mechanisms to Clinical Translation. Pharmaceuticals, 18(10), 1521. https://doi.org/10.3390/ph18101521

Vancouver

Zhou S, Song X, Zeng W, Chen D. Targeting Ion Channels for Cancer Therapy: From Pathophysiological Mechanisms to Clinical Translation. Pharmaceuticals. 2025;18(10):1521. doi:10.3390/ph18101521

BibTeX
@article{Zhou2025,
  author = {Zhou, Sha and Song, Xiong and Zeng, Weian and Chen, Dongtai},
  title = {Targeting Ion Channels for Cancer Therapy: From Pathophysiological Mechanisms to Clinical Translation},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {10},
  pages = {1521},
  doi = {10.3390/ph18101521}
}
Kostenlos starten →